Sign in
AXDX Stock Price, Chart, Stats & News
Accelerate Diagnostics, Inc.
Save
Accelerate Diagnostics, Inc. (AXDX) does not currently pay a dividend.
859,918
Market cap
–
Current P/E
–
Forward P/E
AXDX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 22.53% |
Operating margin | -285.79% |
Pretax margin | -419.51% |
Net margin | -418.37% |
Effective tax rate | 0.27% |
ROA | -84.84% |
ROE | 46.36% |
D/E | -1.19x |
Interest coverage ratio | -2.05x |
AXDX valuation
P/E | – |
P/S | 0.15x |
P/B | -0.01x |
P/CF | -0.10x |
P/FCF | -0.11x |
P/OCF | -0.10x |
PEG | -0.00x |
EV multiple | 3.48x |
About
Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test kit, the Accelerate PhenoTest, this system facilitates quick identification and antimicrobial susceptibility testing (AST) for pathogens responsible for severe or healthcare-associated infections, encompassing both Gram-positive and Gram-negative organisms.
Similar securities
Based on sector and market capitalization
Report issue